Meta-analysis of the efficacy and safety of Ginkgolide Meglumine Injection combined with Butylphthalide in the treatment of Acute Ischemic Stroke
Open Access
- 5 January 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (1) , e0296508
Abstract
Objective: To evaluate the efficacy and safety of Ginkgolide Meglumine Injection (GMI) combined with Butylphthalide in the treatment of Acute Ischemic Stroke (AIS), and provide reference for rational clinical medication. Methods: PubMed, Embase, Web of science, CNKI, Wanfang, VIP and other databases were searched for published studies on the treatment of AIS with GMI combined with Butylphthalide in both Chinese and English. The search period was from the establishment of the database to July 2023. The included studies that met the inclusion criteria were analyzed using RevMan 5.3 software for Meta-analysis. Results: A total of 25 studies involving 2362 patients (experimental group = 1182, control group = 1180) were included. The results of meta-analysis showed that the overall effective rate of the experimental group was significantly higher than that of the control group [RR = 1.21, 95% CI (1.16, 1.26), P< 0.00001]. In addition, compared with the control group, the experimental group showed significant improvement in NIHSS score [SMD = -1.59, % CI (-2.00–1.18), P< 0.00001] and ADL score [SMD = 2.12, 95% CI (1.52, -2.72), P 0.05]. Conclusion: GMI combined with Butylphthalide shows good clinical application effects and good safety in the treatment of AIS. However, more large-sample, multicenter, randomized controlled are needed to confirm these findings.Keywords
Funding Information
- Jiangsu Hengrui Medicine (No. H202047)
- Nantong Municipal Commission of Health and Family Planning (No. QA2021007, QA2021006, QA2021014)
- Institute of Medicinal Plant Development (No. KD2021KYJJZD127)
- Natural Science Foundation of Nantong Municipality (No:QB2019002)
This publication has 11 references indexed in Scilit:
- Global Burden, Risk Factor Analysis, and Prediction Study of Ischemic Stroke, 1990–2030Neurology, 2023
- Efficacy of Diterpene Ginkgolides Meglumine injection in elderly patients with ischemic stroke: A post hoc analysis of a randomized controlled trialPhytomedicine, 2022
- Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic StrokeJournal of Healthcare Engineering, 2022
- Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)International Journal of Molecular Medicine, 2021
- Meta-Analysis of the Effectiveness and Safety of Intravenous Thrombolysis in Patients with Acute Cerebral InfarctionComputational and Mathematical Methods in Medicine, 2021
- Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral InfarctionThe Neurologist, 2021
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Neurology, 2021
- Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implicationsMedicinal Research Reviews, 2021
- [Effects of ginkgolide A, B and K on platelet aggregation].2017
- Chinese Medicine Neuroaid Efficacy on Stroke RecoveryStroke, 2013